日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy

古塞库单抗比阿达木单抗更能降低银屑病患者的疾病和机制相关生物标志物:VOYAGE 1 子研究

Andrew Blauvelt, Richard G Langley, Patrick J Branigan, Xuejun Liu, Yanqing Chen, Samuel DePrimo, Keying Ma, Brittney Scott, Kim Campbell, Ernesto J Muñoz-Elías, Kim A Papp

Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534

RORγt抑制剂JNJ-61803534的临床前和临床表征

Xiaohua Xue, Aimee De Leon-Tabaldo, Rosa Luna-Roman, Glenda Castro, Michael Albers, Freddy Schoetens, Samuel DePrimo, Damayanthi Devineni, Thomas Wilde, Steve Goldberg, Olaf Kinzel, Thomas Hoffmann, Anne M Fourie, Robin L Thurmond